Navigation Links
IronKey Opens New European Office
Date:10/16/2008

Company Opens UK Office to Meet Increased Demand for Secure and Managed USB

Memory Sticks in Europe

LOS ALTOS, Calif., Oct. 15 /PRNewswire/ -- IronKey, maker of the world's most secure flash drive, today announced that the company has opened a new European office in the UK as part of its expansion efforts into more worldwide markets. IronKey's new office will help support its rapid growth in Europe.

IronKey has appointed Jon Fielding as sales director in the UK office. Fielding will head up the company's efforts to market and sell its secure USB memory sticks throughout Europe. Fielding brings over 18 years of experience in IT and sales, most recently leading international sales teams as director of strategic accounts at Tumbleweed, which was acquired by Valicert.

"Having worked in the security space for many years, I am excited to work with a company that has built its product line with security in mind from the ground up," said Jon Fielding, director of sales for IronKey UK. "I look forward to working closely with our strong partner channel in EMEA to address the rapidly growing market demand for secure mobile data storage solutions."

The company selected the UK because of its central location for ease of travel throughout Europe and proximity to IronKey partners. IronKey's rugged, waterproof and tamper-resistant USB memory sticks with cross-platform support and remote policy enforcement enable solutions that can be rapidly deployed in heterogeneous environments with complete control. Featuring always-on military-grade hardware encryption, strong authentication, portable applications and ultra-fast memory, IronKey delivers unique market opportunities for its channel partners and unprecedented mobile data security solutions for customers.

"We are dedicated to providing industry leading solutions and unparalleled support to our customers as we expand our presence in Europe," said Stewart Fox, vice pre
'/>"/>

SOURCE IronKey
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Landmark study opens door to new cancer, aging treatments
2. Brown opens institute for molecular and nanoscale innovation
3. European light research opens door for optical storage and computing
4. New window opens on the secret life of microbes
5. Experimental Biology and Medicine announces expansion into Asia, opens new office
6. Electronic switch opens doors in rheumatoid joints
7. Profound immune system discovery opens door to halting destruction of lupus
8. Truck-safe bamboo bridge opens in China
9. Cold treatment opens doors for citrus exports to Japan
10. IdentiPHI Opens Paris Office to Boost European Sales and Support
11. Same gene protects from 1 disease, opens door to another
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2014)... , December 9, 2014 ... BCARD Platform   ... meeting scheduling solutions for business-to-business (B2B) events, today ... leader in mobile near-field communication (NFC), Bluetooth low ...      (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow will ...
(Date:12/3/2014)... As part of our commitment to offering ... to announce the release of a new reader that ... workforce data that they need. The Atlas ... existing readers. Many such devices have serious shortcomings when ... Older models force users to navigate numerous complicated steps ...
(Date:11/21/2014)... Calif. , Nov. 20, 2014   Atmel® ... leader in microcontroller (MCU) and touch technology solutions, today ... temperature sensors with the widest V cc ... higher temperature accuracy and faster I 2 C bus ... and serial EEPROM memory making them ideal for consumer, ...
Breaking Biology News(10 mins):Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Inception Technologies to Release New Biometric Reader 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4
... to the U.S. Food and Drug Administration,s (FDA) invitation ... Draft Guidance on mobile medical applications, AMIAthe association for ... oversight of clinical decision support systems. The critical factor, ... types of software that provide clinical decision support (CDS) ...
... 14, 2011 As the United States nears another ... (BGU) have determined scientifically, for the first time, that ... According to Prof. Hagit Cohen from the Anxiety ... Sciences, "We understand that emotional changes are related and ...
... sea turtles accidentally caught and killed in fishing gear in ... percent since 1990, according to a new study by researchers ... report, published in the scientific journal Biological Conservation , ... into place over the last 20 years to reduce bycatch ...
Cached Biology News:AMIA advises FDA on clinical decision support 2Voting causes stress according to Ben-Gurion University of the Negev study 2Accidental sea turtle deaths drop 90 percent in US fisheries 2Accidental sea turtle deaths drop 90 percent in US fisheries 3
(Date:12/13/2014)... The “Global Synthetic Biology Market (2013-2018)”, analyses and ... challenges. , The global synthetic biology market is ... Scientific, Inc. (U.S.), DuPont (U.S.), and Royal DSM ... ~65% of the total synthetic biology market. ... @ http://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.html , Thermo Fisher Scientific, ...
(Date:12/13/2014)... , Dec. 12, 2014  Vermillion, Inc. (NasdaqCM: VRML), a ... the appointments of Veronica G. H. Jordan , ... Company,s Board of Directors, bringing the total number of ... Jim LaFrance , Chairman, President, and ... pleased to announce the appointments of Veronica and David ...
(Date:12/13/2014)... SAN ANTONIO , Dec. 12, 2014 ... the presentation of data at the San Antonio Breast ... evaluating epoetin alfa plus best supportive care (BSC) versus ... metastatic breast cancer receiving standard chemotherapy. This non-inferiority trial ... rule out a 15 percent or greater increase in ...
(Date:12/12/2014)... December 11, 2014 Pittcon is ... that includes over 2,000 technical presentations offered ... This year’s program covers a wide range ... biotechnology, biomedical, drug discovery, environmental, food science, fuels/energy, ... and water/wastewater. The Technical Program begins on ...
Breaking Biology Technology:Synthetic Biology Market to HIt $5.6304 Billion by 2018 - New Research Report by MarketsandMakets 2Synthetic Biology Market to HIt $5.6304 Billion by 2018 - New Research Report by MarketsandMakets 3Vermillion Strengthens Board of Directors with Appointments of Veronica Jordan, Ph.D., and David Schreiber 2Vermillion Strengthens Board of Directors with Appointments of Veronica Jordan, Ph.D., and David Schreiber 3Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 2Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 3Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 4Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 5Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 6Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 7Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 8Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 9Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 10Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 11Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 12Pittcon Announces a Diverse 2015 Technical Program - Renowned Speakers, Special Symposia and Co-programming 2Pittcon Announces a Diverse 2015 Technical Program - Renowned Speakers, Special Symposia and Co-programming 3
... - Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT - ... the fiscal 2009 third quarter and nine-month period ended ... for its fiscal year 2009 now ending on February, ... period ended February 28, 2009 in the range of ...
... regular improvements in information technology, says Slava Rotkin, but ... Take the laptop, for example. Its components, especially its ... while the instrument,s power and capacity increase. But heat ... melt and the laptop hardware to fail. , Indeed, ...
... Approval for SIMPONI , ... Ortho Biotech Inc. and Schering-Plough Corporation (NYSE: ... granted approval of SIMPONI (TM) (golimumab),as a once-monthly, ... active rheumatoid arthritis (RA), active psoriatic arthritis (PsA),and ...
Cached Biology Technology:Neptune Technologies to expect Record Revenues; Fiscal 2009 Third Quarter and Year-End Results 2Neptune Technologies to expect Record Revenues; Fiscal 2009 Third Quarter and Year-End Results 3Neptune Technologies to expect Record Revenues; Fiscal 2009 Third Quarter and Year-End Results 4Neptune Technologies to expect Record Revenues; Fiscal 2009 Third Quarter and Year-End Results 5New 'near-field' radiation therapy promises relief for overheating laptops 2New 'near-field' radiation therapy promises relief for overheating laptops 3Health Canada Approves SIMPONI(TM) (golimumab) for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 2Health Canada Approves SIMPONI(TM) (golimumab) for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 3Health Canada Approves SIMPONI(TM) (golimumab) for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 4Health Canada Approves SIMPONI(TM) (golimumab) for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 5Health Canada Approves SIMPONI(TM) (golimumab) for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 6Health Canada Approves SIMPONI(TM) (golimumab) for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 7Health Canada Approves SIMPONI(TM) (golimumab) for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 8
Please email us with project details and we will respond within 24 hours to your query!...
Makes gels easy to load and track during electrophoresis. 10X concentrate of Bromophenol Blue, glycerol solution....
Request Info...
Request Info...
Biology Products: